Stocks News

LAST PRICE
12.9300
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
12.6100/ 1
Ask / Lots
13.3900/ 1
Open / Previous Close
12.6200 / 12.9300
Day Range
Low 12.6200
High 13.0516
52 Week Range
Low 10.1000
High 13.1500
Volume
167,781
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 16, 2023
- Merrimack Pharmaceuticals Insider Bought Shares Worth $627,125, According to a Recent SEC Filing, from 5:11PM ET on Thursday Nov 16, 2023 by MT Newswires
  5:11PM ET on Thursday Nov 16, 2023 by MT Newswires
  Companies Mentioned: MACK
  05:11 PM EST, 11/16/2023 (MT Newswires) -- Eric Andersen, Director, on November 14, 2023, executed a purchase for 50,170 shares in Merrimack Pharmaceuticals (MACK) for $627,125. Following the Form 4 filing with the SEC, Andersen has control over a t...

Nov 29, 2023
- INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breast Cancer with MUC4 Expression in Poster Presented at San Antonio Breast Cancer Symposium, from 8:00AM ET on Wednesday Nov 29, 2023 by GlobeNewswire
  8:00AM ET on Wednesday Nov 29, 2023 by GlobeNewswire
  Companies Mentioned: INMB
Nov 27, 2023
- Aldeyra NDA for Reproxalap Did Not Demonstrate Efficacy for Dry Eye Treatment, from 5:06PM ET on Monday Nov 27, 2023 by MT Newswires
  5:06PM ET on Monday Nov 27, 2023 by MT Newswires
  Companies Mentioned: ALDX
- --Aldeyra Therapeutics Halted After-Hours - FDA Says NDA Did Not Demonstrate 'Efficacy in Treating Ocular Symptoms Associated With Dry Eyes'; Additional Study Recommended, from 4:11PM ET on Monday Nov 27, 2023 by MT Newswires
  4:11PM ET on Monday Nov 27, 2023 by MT Newswires
  Companies Mentioned: ALDX
- Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Dry Eye Disease, from 4:07PM ET on Monday Nov 27, 2023 by Business Wire
  4:07PM ET on Monday Nov 27, 2023 by Business Wire
  Companies Mentioned: ALDX
- INmune Bio Gets Authorization in France, Spain for Phase II Trial of XPro for Early Alzheimer's Disease, from 10:54AM ET on Monday Nov 27, 2023 by MT Newswires
  10:54AM ET on Monday Nov 27, 2023 by MT Newswires
  Companies Mentioned: INMB
- INmune Bio Receives EMA's Authorization in France and Spain for Phase II Clinical Trial of XPro(TM) for Early Alzheimer's Disease, from 8:00AM ET on Monday Nov 27, 2023 by GlobeNewswire
  8:00AM ET on Monday Nov 27, 2023 by GlobeNewswire
  Companies Mentioned: INMB
Nov 22, 2023
- Thinking about trading options or stock in Verizon Communications, Applied Therapeutics, Adobe, VinFast Auto, or ArcelorMittal?, from 9:31AM ET on Wednesday Nov 22, 2023 by PR Newswire
  9:31AM ET on Wednesday Nov 22, 2023 by PR Newswire
  Companies Mentioned: VZ, ADBE, APLT, VFS
Nov 15, 2023
- INmune Bio Inc. Announces Expansion of Phase II Clinical Trial for Alzheimer's Disease in Europe, from 9:00AM ET on Wednesday Nov 15, 2023 by GlobeNewswire
  9:00AM ET on Wednesday Nov 15, 2023 by GlobeNewswire
  Companies Mentioned: INMB
Nov 9, 2023
- Omeros Corporation Reports Third Quarter 2023 Financial Results, from 4:02PM ET on Thursday Nov 09, 2023 by Business Wire
  4:02PM ET on Thursday Nov 09, 2023 by Business Wire
  Companies Mentioned: OMER
- Thinking about buying stock in Applied Therapeutics, Motus GI Holdings, Plug Power, Kinnate Biopharma, or Virgin Galactic Holdings?, from 9:31AM ET on Thursday Nov 09, 2023 by PR Newswire
  9:31AM ET on Thursday Nov 09, 2023 by PR Newswire
  Companies Mentioned: PLUG, SPCE, MOTS, APLT, KNTE

Merrimack Pharmaceuticals Inc
NASDAQ:MACKUnited States

Search Criteria

Nov 16, 2023

Merrimack Pharmaceuticals Insider Bought Shares Worth $627,125, According to a Recent SEC Filing, from 5:11PM ET on Thursday Nov 16, 2023 by MT Newswires

Peers Headlines

Nov 29, 2023

INmune Bio Inc. Demonstrates that INB03 Enhances the Uptake of Trastuzumab Deruxtecan in HER2+ Breast Cancer with MUC4 Expression in Poster Presented at San Antonio Breast Cancer Symposium, from 8:00AM ET on Wednesday Nov 29, 2023 by GlobeNewswire

Nov 27, 2023

Aldeyra NDA for Reproxalap Did Not Demonstrate Efficacy for Dry Eye Treatment, from 5:06PM ET on Monday Nov 27, 2023 by MT Newswires

--Aldeyra Therapeutics Halted After-Hours - FDA Says NDA Did Not Demonstrate 'Efficacy in Treating Ocular Symptoms Associated With Dry Eyes'; Additional Study Recommended, from 4:11PM ET on Monday Nov 27, 2023 by MT Newswires

Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Dry Eye Disease, from 4:07PM ET on Monday Nov 27, 2023 by Business Wire

INmune Bio Gets Authorization in France, Spain for Phase II Trial of XPro for Early Alzheimer's Disease, from 10:54AM ET on Monday Nov 27, 2023 by MT Newswires

INmune Bio Receives EMA's Authorization in France and Spain for Phase II Clinical Trial of XPro(TM) for Early Alzheimer's Disease, from 8:00AM ET on Monday Nov 27, 2023 by GlobeNewswire

Nov 22, 2023

Thinking about trading options or stock in Verizon Communications, Applied Therapeutics, Adobe, VinFast Auto, or ArcelorMittal?, from 9:31AM ET on Wednesday Nov 22, 2023 by PR Newswire

Nov 15, 2023

INmune Bio Inc. Announces Expansion of Phase II Clinical Trial for Alzheimer's Disease in Europe, from 9:00AM ET on Wednesday Nov 15, 2023 by GlobeNewswire

Nov 9, 2023

Omeros Corporation Reports Third Quarter 2023 Financial Results, from 4:02PM ET on Thursday Nov 09, 2023 by Business Wire

Thinking about buying stock in Applied Therapeutics, Motus GI Holdings, Plug Power, Kinnate Biopharma, or Virgin Galactic Holdings?, from 9:31AM ET on Thursday Nov 09, 2023 by PR Newswire